Aug 5 (Reuters) - DaVita ( DVA ) beat Wall Street

estimates for second-quarter profit on Tuesday, driven by

demand for its kidney dialysis services.

The company provides kidney care services for patients with

chronic kidney failure through a network of outpatient clinics

and at-home dialysis across the United States.

DaVita ( DVA ), which had been grappling with rising patient care

and operating costs, has also experienced disruptions from

hurricanes and a ransomware attack in April, which affected some

of its operations.

The company said its higher IT expenses and costs tied to

the cybersecurity incident led to a 10% rise in general and

administrative costs from the first quarter.

Earlier in the day, DaVita's ( DVA ) peer Fresenius Medical Care

missed quarterly profit expectations after a severe

flu season in the U.S. led to higher mortality among patients

and a greater number of missed treatments earlier this year.

However, DaVita ( DVA ) reported quarterly revenue of $3.38 billion,

compared to analysts' estimates of $3.36 billion, according to

LSEG data.

The company said it benefited from seasonal factors,

including more patients meeting their co-insurance and

deductibles, meaning insurance kicked in to cover treatment

costs.

On an adjusted basis, DaVita ( DVA ) reported a second-quarter

profit of $2.95 per share for the quarter, above analysts'

estimates of $2.77 per share.